Puma Biotechnology (ticker symbol PBYI) opened trading on Wednesday up more than 290 percent or $169 on news that the company released positive results of its initial treatment for breast cancer.

The trial showed that with treatment, clients showed a 33 percent improvement in disease-free survival versus placebo, according to a press release from the company.